McCarthy Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

McCarthy Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-110	Closed	-$4K	–	151
2022 Q1	$4K	Hold	110	–	–	﹤0.01%	214
2021 Q4	$3K	Hold	110	–	–	﹤0.01%	238
2021 Q3	$4K	Hold	110	–	–	﹤0.01%	218
2021 Q2	$4K	Buy	+110	New	+$4.31K	﹤0.01%	265

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

McCarthy Asset Management's IONS Position: Q2 2022 in Review

McCarthy Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2022, closing a stake of 110 shares — an estimated $4K sold.

McCarthy Asset Management first reported a position in IONS in Q2 2021 and held it in 4 quarters. The position peaked at $4K in Q1 2022. 349 funds tracked by Wall St. Rank hold IONS as of Q2 2022.

McCarthy Asset Management reported no remaining Ionis Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
McCarthy Asset Management sold 110 Ionis Pharmaceuticals shares in Q2 2022, an estimated $4K.
McCarthy Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2021 and held it in 4 quarters.
McCarthy Asset Management's Ionis Pharmaceuticals position peaked at $4K in Q1 2022.
349 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2022.

Based on McCarthy Asset Management's 13F filing for Q2 2022, filed 20 Jul 2022.